Visual outcome of ranibizumab therapy for neovascular age related macular degeneration in the black population: a report of five cases
Roopa Vemala, Bhaskar Gupta, Sobha SivaprasadLaser and Retinal Research Unit, King’s College Hospital, London SE5 9RS, UKIntroduction: Neovascular age related macular degeneration (AMD) is relatively uncommon in the black population. We report the 12-month outcome of ranibizumab therap...
Main Authors: | Roopa Vemala, Bhaskar Gupta, Sobha Sivaprasad |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2010-08-01
|
Series: | Clinical Ophthalmology |
Online Access: | http://www.dovepress.com/visual-outcome-of-ranibizumab-therapy-for-neovascular-age-related-macu-a5003 |
Similar Items
-
Caregiver Burden in Patients Receiving Ranibizumab Therapy for Neovascular Age Related Macular Degeneration.
by: Rishma Gohil, et al.
Published: (2015-01-01) -
Quality of fixation in eyes with neovascular age-related macular degeneration treated with ranibizumab.
by: Sivaprasad, S, et al.
Published: (2011) -
Role of pegaptanib sodium in the treatment of neovascular age-related macular degeneration
by: Sobha Sivaprasad
Published: (2008-06-01) -
Intravitreal aflibercept in neovascular age-related macular degeneration previously treated with ranibizumab
by: Rachel Hui Fen Lim, et al.
Published: (2017-03-01) -
Comparing fixation location and stability in patients with neovascular age-related macular degeneration treated with or without Ranibizumab.
by: Pearce, E, et al.
Published: (2011)